Start Date
September 1, 2022
Primary Completion Date
September 30, 2024
Study Completion Date
January 31, 2026
Bendamustine Hydrochloride
To be given by IV at 70mg/m2 on cycle days 1 and 8 for up to 6 cycles
Isatuximab
To be given by IV at10mg/kg IV on cycle 1 days 1,8,15, and 22; cycle 2-6 days 1,8; and cycle 7-12 days 1
Collaborators (1)
Sanofi
INDUSTRY
Tufts Medical Center
OTHER